Policy Briefings

Lonza Integrates ADC Platform into Advanced Synthesis Portfolio to Expand Bioconjugate Support

Johnson & Johnson Invests More Than $1 Billion in Pennsylvania Cell Therapy Manufacturing Facility

Rezon Bio Receives FDA Approval for Commercial Biosimilar Manufacturing at Warsaw-Duchnice Site

Catalent Partners with S.Biomedics to Advance TED-A9 Cell Therapy for Parkinson’s Disease

ValGenesis Enables Digital Logbook Transformation at Sterile Fill-Finish CDMO

Pluri Inc. Strengthens Cell Therapy Platform with CNIPA Grant for 3D Bioreactor System

Axplora Announces Multi-Million-Euro Investment to Expand ADC Lyophilization at Le Mans Site

Andelyn Biosciences Selected to Manufacture Clinical-Grade AAV for NKH Gene Therapy

BIOEMTECH Partners with NorthStar to Provide Actinium-225 for Targeted Radiotherapeutic Research

Scinai Immunotherapeutics Acquires Recipharm Israel and Expands CDMO Platform

ProBioGen Launches CMC Navigator™ With Four Defined CMC Service Models

Terumo expands its Drug Product operations in Germany [CDMO Spotlight]

OneSource Specialty Pharma Receives SFDA Approval for Generic Semaglutide in Saudi Arabia

Shilpa Medicare Enters Binding Agreement with NXI Therapeutics AG for Autoimmune NCE Development

Ampersand Capital Partners Acquires Purna Pharmaceuticals to Expand Life Sciences Portfolio

Altasciences Appoints Marie-Hélène Raigneau as CEO and Names Chris Perkin to Board

WuXi Vaccines Achieves ANVISA GMP Approval for DP17 Site in Suzhou

Syngene International Partners with Johns Hopkins University to Advance Early-Stage Drug Discovery